Italy ends ban on Novartis flu vaccine

Italy lifted a ban on Novartis' ($NVS) flu vaccine several weeks after halting distribution due to small particles found in some injections. Other countries, such as Canada and Switzerland, ended a similar ban after accepting that the drugmaker had shown that the vaccines posed no safety risk. Story

Suggested Articles

A Lancet Infectious Diseases study shows antibody response persists for two years or more after a single shot of Merck’s rVSV-ZEBOV vaccine.

The partnership aims to make the production of vaccines that use adenovirus as vectors more cost-effective and contamination-free.

The FDA is evaluating the possibility of prosecuting those involved in rogue herpes vaccine research led by a Southern Illinois University professor.